(Q37978096)

26 August 2017

title

Screening for hydroxychloroquine retinal toxicity: is it necessary? (English)

1 reference

26 August 2017

0 references

Morsman CD

1

1 reference

26 August 2017

Livesey SJ

2

1 reference

26 August 2017

Richards IM

3

1 reference

26 August 2017

Jessop JD

4

1 reference

26 August 2017

Mills PV

5

1 reference

26 August 2017

publication date

1 January 1990

1 reference

26 August 2017

1 reference

26 August 2017

volume

4 ( Pt 4)

1 reference

26 August 2017

page(s)

572-576

1 reference

Hydroxychloroquine in the treatment of rheumatoid arthritis

26 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.79

Chloroquine retinopathy: is there a safe daily dose?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.79

Dose refinements in long-term therapy of rheumatoid arthritis with antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.79

Ophthalmologic safety of long-term hydroxychloroquine sulfate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.79

Hydroxychloroquine treatment and the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.79

Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.79

Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.79

Ocular lesions in rheumatoid arthritis and related disorders with particular reference to retinopathy. A study of 741 patients treated with and without chloroquine drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.79

Evaluation of several tests in screening for chloroquine maculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.79

Electroretinography in Patients with Connective Tissue Diseases Treated with Hydroxychloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.79

Ocular Changes Induced by Long-Term Hydroxychloroquine (Plaquenil) Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.79

7 January 2021

Screening for antimalarial maculopathy in rheumatology clinics

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.79

7 January 2021

Screening: the need for a balance

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.79

7 January 2021

Safety of hydroxychloroquine

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.79

7 January 2021

Antimalarial therapy and early retinal changes in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1038%2FEYE.1990.79

7 January 2021

Identifiers

DOI

10.1038/EYE.1990.79

1 reference

26 August 2017

1 reference